Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Melanoma	4/72	0.0035944169845619624	0.34292673226544457	0	0	6.836678200692042	38.479378241442575	CDKN1A;E2F1;MITF;FGFR1
Arrhythmogenic right ventricular cardiomyopathy	4/77	0.004572356430205928	0.34292673226544457	0	0	6.366800966962128	34.30258277842423	DSP;GJA1;CDH2;SLC8A1
Signaling pathways regulating pluripotency of stem cells	5/143	0.008335277912761332	0.38413744795051513	0	0	4.220907297830375	20.206574003572094	ID2;HAND1;ACVR2A;TBX3;FGFR1
Prostate cancer	4/97	0.010243665278680404	0.38413744795051513	0	0	4.992536369386464	22.871287323467445	CREBBP;CDKN1A;E2F1;FGFR1
HIF-1 signaling pathway	4/109	0.015187140350627983	0.4556142105188395	0	0	4.419271708683473	18.504843996629166	CREBBP;CDKN1A;EDN1;NPPA
Adherens junction	3/71	0.02402859810464502	0.5061497021449969	0	0	5.097523219814241	19.00616920751781	CREBBP;SORBS1;FGFR1
p53 signaling pathway	3/73	0.025823029538262366	0.5061497021449969	0	0	4.951378446115288	18.104658681283354	CDKN1A;CASP8;IGFBP3
Kaposi sarcoma-associated herpesvirus infection	5/193	0.026994650781066498	0.5061497021449969	0	0	3.0904570061689536	11.1630909046888	CREBBP;CDKN1A;CASP8;E2F1;PIK3C3
Hypertrophic cardiomyopathy	3/90	0.04387916148437294	0.6251435643824572	0	0	3.980439604759024	12.444111040411421	EDN1;SLC8A1;MYH6
TGF-beta signaling pathway	3/94	0.0488407810743851	0.6251435643824572	0	0	3.804704067861963	11.487123094885487	CREBBP;ID2;ACVR2A
Bladder cancer	2/41	0.04946076084945932	0.6251435643824572	0	0	5.899522957662493	17.73736197602507	CDKN1A;E2F1
Hepatitis B	4/162	0.05326210857242798	0.6251435643824572	0	0	2.9289650037230084	8.589278062241606	CREBBP;CDKN1A;CASP8;E2F1
Melanogenesis	3/101	0.058151513319832406	0.6251435643824572	0	0	3.531686358754028	10.046600107506606	CREBBP;EDN1;MITF
Parathyroid hormone synthesis, secretion and action	3/106	0.06527659954981196	0.6251435643824572	0	0	3.3593936297053313	9.168193919001311	CDKN1A;BGLAP;FGFR1
Tuberculosis	4/180	0.07248896077135715	0.6251435643824572	0	0	2.627005347593583	6.894105284876429	CREBBP;CIITA;CASP8;PIK3C3
Transcriptional misregulation in cancer	4/192	0.08701807494074264	0.6251435643824572	0	0	2.4578222778473093	6.001115770695566	CDKN1A;IGFBP3;ID2;MITF
Thyroid hormone signaling pathway	3/121	0.08888152344401863	0.6251435643824572	0	0	2.930121914956884	7.0922164996600126	NCOA2;CREBBP;MYH6
Notch signaling pathway	2/59	0.09338023468898816	0.6251435643824572	0	0	4.032843737250102	9.562177287921063	TLE3;CREBBP
Cell cycle	3/124	0.0939796574881784	0.6251435643824572	0	0	2.857039292445991	6.755974902471492	CREBBP;CDKN1A;E2F1
Viral myocarditis	2/60	0.09606874260426201	0.6251435643824572	0	0	3.963111467522053	9.28434665671665	CASP8;MYH6
FoxO signaling pathway	3/131	0.10632775304418685	0.6251435643824572	0	0	2.6998355263157894	6.050949529535229	CREBBP;CDKN1A;SOD2
Apelin signaling pathway	3/137	0.11738875691146503	0.6251435643824572	0	0	2.5781618224666145	5.523103628509171	PIK3C3;PPARGC1A;SLC8A1
Insulin signaling pathway	3/137	0.11738875691146503	0.6251435643824572	0	0	2.5781618224666145	5.523103628509171	SREBF1;SORBS1;PPARGC1A
Mitophagy	2/68	0.11832051312176751	0.6251435643824572	0	0	3.481324876673714	7.43039403232467	E2F1;MITF
Renal cell carcinoma	2/69	0.12118666841614661	0.6251435643824572	0	0	3.42919125303714	7.237044804954796	CDKN1A;CREBBP
Renin secretion	2/69	0.12118666841614661	0.6251435643824572	0	0	3.42919125303714	7.237044804954796	EDN1;NPPA
Huntington disease	5/306	0.12913966556528775	0.6251435643824572	0	0	1.9191452554601034	3.9282231573911557	CREBBP;CASP8;PIK3C3;SOD2;PPARGC1A
Non-small cell lung cancer	2/72	0.12988541415193172	0.6251435643824572	0	0	3.2817275747508305	6.698342838948271	CDKN1A;E2F1
MicroRNAs in cancer	5/310	0.13426793779821375	0.6251435643824572	0	0	1.8935881268794257	3.802169570240208	CREBBP;CDKN1A;STMN1;E2F1;RECK
Breast cancer	3/147	0.1367198872981301	0.6251435643824572	0	0	2.3979044834307994	4.771400851792669	CDKN1A;E2F1;FGFR1
Cell adhesion molecules	3/148	0.13871037787917606	0.6251435643824572	0	0	2.3812462189957655	4.703835514136267	CDH2;NRXN3;CD34
Glioma	2/75	0.13872412373975015	0.6251435643824572	0	0	3.1463841987894234	6.214952147282103	CDKN1A;E2F1
Chronic myeloid leukemia	2/76	0.1416992079266903	0.6251435643824572	0	0	3.103708359522313	6.064797353669579	CDKN1A;E2F1
Pancreatic cancer	2/76	0.1416992079266903	0.6251435643824572	0	0	3.103708359522313	6.064797353669579	CDKN1A;E2F1
Cellular senescence	3/156	0.15497875233290428	0.6359226381478472	0	0	2.255819286779039	4.205901189297352	CDKN1A;IGFBP3;E2F1
Hepatitis C	3/157	0.15705330993208885	0.6359226381478472	0	0	2.2410571884256094	4.148577785212032	CDKN1A;CASP8;E2F1
Cardiac muscle contraction	2/87	0.17522795673843025	0.6359226381478472	0	0	2.700547195622435	4.703455398374708	SLC8A1;MYH6
Wnt signaling pathway	3/166	0.176097808026349	0.6359226381478472	0	0	2.1163491550963296	3.675496827365201	TLE3;CREBBP;CTNNBIP1
cGMP-PKG signaling pathway	3/167	0.17825289378747747	0.6359226381478472	0	0	2.1033376123234917	3.627315055273013	NPPA;SLC8A1;MYH6
Pathways in cancer	7/531	0.18126763213953678	0.6359226381478472	0	0	1.54401883256388	2.6368455769079366	CREBBP;CDKN1A;EDN1;CASP8;E2F1;MITF;FGFR1
Proximal tubule bicarbonate reclamation	1/23	0.1821580043309876	0.6359226381478472	0	0	5.203363110877562	8.86070720390759	SLC4A4
Bile secretion	2/90	0.18458327478037875	0.6359226381478472	0	0	2.608086680761099	4.406765562172062	KCNN2;SLC4A4
Influenza A	3/172	0.18913541404420445	0.6359226381478472	0	0	2.040589639779923	3.398177692285818	CREBBP;CIITA;CASP8
Small cell lung cancer	2/92	0.19085987421619519	0.6359226381478472	0	0	2.5498708010335918	4.223136214362436	CDKN1A;E2F1
IL-17 signaling pathway	2/94	0.1971648120711496	0.6359226381478472	0	0	2.494186046511628	4.049848021094101	USP25;CASP8
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/26	0.20334368249673665	0.6359226381478472	0	0	4.578265895953757	7.292526150272238	PIGC
Maturity onset diabetes of the young	1/26	0.20334368249673665	0.6359226381478472	0	0	4.578265895953757	7.292526150272238	NKX6-1
Dilated cardiomyopathy	2/96	0.2034952442073111	0.6359226381478472	0	0	2.4408708560118755	3.8861413531092848	SLC8A1;MYH6
Longevity regulating pathway	2/102	0.22261238677367096	0.6525395000910464	0	0	2.293720930232558	3.445910158192597	SOD2;PPARGC1A
Pentose phosphate pathway	1/30	0.23074476795617313	0.6525395000910464	0	0	3.9459836555710583	5.786560425251395	TKT
Glucagon signaling pathway	2/107	0.23864949862511786	0.6525395000910464	0	0	2.183942414174972	3.1290638840951233	CREBBP;PPARGC1A
Insulin resistance	2/108	0.24186488445916798	0.6525395000910464	0	0	2.1632294866169373	3.07043609676624	SREBF1;PPARGC1A
SNARE interactions in vesicular transport	1/33	0.2506787605645003	0.6525395000910464	0	0	3.5755057803468207	4.9470090066933246	GOSR2
TNF signaling pathway	2/112	0.25474356949262794	0.6525395000910464	0	0	2.0841437632135307	2.8500621144962324	EDN1;CASP8
Toxoplasmosis	2/112	0.25474356949262794	0.6525395000910464	0	0	2.0841437632135307	2.8500621144962324	CIITA;CASP8
Epstein-Barr virus infection	3/202	0.25737032717190184	0.6525395000910464	0	0	1.730318257956449	2.3484558884619355	CDKN1A;CASP8;E2F1
Serotonergic synapse	2/113	0.2579661794916574	0.6525395000910464	0	0	2.0652629373559606	2.7982800820005016	KCNN2;SLC6A4
Viral carcinogenesis	3/203	0.25970870146149966	0.6525395000910464	0	0	1.721578947368421	2.3210235350965713	CREBBP;CDKN1A;CASP8
Nicotinate and nicotinamide metabolism	1/35	0.26368189996680735	0.6525395000910464	0	0	3.3648418905134307	4.485374035060237	NT5C1B
African trypanosomiasis	1/37	0.27646066709821937	0.6525395000910464	0	0	3.1775850995504173	4.085378967174108	NPPA
Aldosterone-regulated sodium reabsorption	1/37	0.27646066709821937	0.6525395000910464	0	0	3.1775850995504173	4.085378967174108	NR3C2
Thyroid cancer	1/37	0.27646066709821937	0.6525395000910464	0	0	3.1775850995504173	4.085378967174108	CDKN1A
Growth hormone synthesis, secretion and action	2/119	0.2773068109258943	0.6525395000910464	0	0	1.9587557145696681	2.5123603407889954	CREBBP;IGFBP3
AMPK signaling pathway	2/120	0.28052880883450193	0.6525395000910464	0	0	1.9420575482853764	2.4685082828783185	SREBF1;PPARGC1A
Primary immunodeficiency	1/38	0.28276711670612015	0.6525395000910464	0	0	3.0915481955944384	3.9050323092993637	CIITA
cAMP signaling pathway	3/216	0.2903286018687588	0.6598377315199064	0	0	1.6154353018696976	1.9978765045200282	CREBBP;EDN1;NPPA
Human T-cell leukemia virus 1 infection	3/219	0.29743846531832857	0.6659070119067056	0	0	1.5927550357374918	1.9312917971425587	CREBBP;CDKN1A;E2F1
Purine metabolism	2/129	0.30945406438158773	0.6775805342296842	0	0	1.8036073979124703	2.115533391578695	NT5C1B;AMPD3
Human cytomegalovirus infection	3/225	0.31168704574565476	0.6775805342296842	0	0	1.5492334439702862	1.8060276452489754	CDKN1A;CASP8;E2F1
Vascular smooth muscle contraction	2/133	0.32224265010969405	0.6840321357161306	0	0	1.7481803657021127	1.9797276338857674	EDN1;NPPA
Human papillomavirus infection	4/331	0.32546988383830666	0.6840321357161306	0	0	1.4030581039755352	1.574912159032004	CREBBP;CDKN1A;CASP8;E2F1
Thermogenesis	3/232	0.3283354251437427	0.6840321357161306	0	0	1.5013406879644526	1.6720724836572602	NPPA;PPARGC1A;FGFR1
Fluid shear stress and atherosclerosis	2/139	0.34131229664958773	0.7013266369512078	0	0	1.671108470548294	1.7963704080281824	EDN1;ACVR2A
N-Glycan biosynthesis	1/50	0.3543133002736421	0.709740600344437	0	0	2.333018756635602	2.4206789693623425	ALG10B
Endocrine and other factor-regulated calcium reabsorption	1/53	0.3710618397239662	0.709740600344437	0	0	2.1980880391285016	2.1791549097350225	SLC8A1
Gastric cancer	2/149	0.37270538814318754	0.709740600344437	0	0	1.5566366081316247	1.5363489874230396	CDKN1A;E2F1
Adrenergic signaling in cardiomyocytes	2/150	0.37581328621323506	0.709740600344437	0	0	1.5460402262727844	1.5130521157361128	SLC8A1;MYH6
Regulation of lipolysis in adipocytes	1/55	0.3819868368241707	0.709740600344437	0	0	2.1164632840933417	2.0368189284263143	NPPA
Pyrimidine metabolism	1/56	0.38737836839620887	0.709740600344437	0	0	2.0778770362585393	1.9705616845278418	NT5C1B
Oxytocin signaling pathway	2/154	0.3881811055467625	0.709740600344437	0	0	1.5050489596083232	1.4242026681470594	CDKN1A;NPPA
Cushing syndrome	2/155	0.3912565049960906	0.709740600344437	0	0	1.4951360389116888	1.403023564875776	CDKN1A;E2F1
Non-alcoholic fatty liver disease	2/155	0.3912565049960906	0.709740600344437	0	0	1.4951360389116888	1.403023564875776	SREBF1;CASP8
Legionellosis	1/57	0.39272313219058846	0.709740600344437	0	0	2.0406688687035506	1.9073120022179917	CASP8
Endometrial cancer	1/58	0.39802153164960413	0.7107527350885788	0	0	2.004766250887334	1.8468892557781884	CDKN1A
Mineral absorption	1/60	0.40848083362688503	0.7196269067564258	0	0	1.9366121289311258	1.7338687564851867	SLC8A1
JAK-STAT signaling pathway	2/162	0.4125860932070175	0.7196269067564258	0	0	1.4292151162790698	1.265298983668287	CREBBP;CDKN1A
Basal cell carcinoma	1/63	0.4238319403011306	0.7256860360358872	0	0	1.8426253962334513	1.5817433040428577	CDKN1A
GnRH secretion	1/64	0.4288604323247804	0.7256860360358872	0	0	1.8132856225341774	1.535170665524538	KCNN2
Hepatocellular carcinoma	2/168	0.4305737147146264	0.7256860360358872	0	0	1.3771364527878958	1.1604257701606255	CDKN1A;E2F1
Aminoacyl-tRNA biosynthesis	1/66	0.43878688447567743	0.7310554639418194	0	0	1.7573143619386393	1.4475726640104076	FARS2
Long-term potentiation	1/67	0.4436855944009923	0.7310554639418194	0	0	1.7306008057453144	1.4063538606534318	CREBBP
Adipocytokine signaling pathway	1/69	0.4533558321960898	0.7310554639418194	0	0	1.6795307718463108	1.3286397772656142	PPARGC1A
Central carbon metabolism in cancer	1/70	0.4581280907368735	0.7310554639418194	0	0	1.6551059730250481	1.2919864143152329	FGFR1
RIG-I-like receptor signaling pathway	1/70	0.4581280907368735	0.7310554639418194	0	0	1.6551059730250481	1.2919864143152329	CASP8
Inositol phosphate metabolism	1/73	0.47219774309377993	0.7373295375890596	0	0	1.5859023763648041	1.1899936375416538	PIK3C3
MAPK signaling pathway	3/294	0.4725767840198013	0.7373295375890596	0	0	1.1777295472357872	0.8827731171678783	STMN1;MAPT;FGFR1
PPAR signaling pathway	1/74	0.4768064343075919	0.7373295375890596	0	0	1.5640985034444532	1.1584412176622558	SORBS1
Synaptic vesicle cycle	1/78	0.4948445060126242	0.7497644030494306	0	0	1.4825463553787253	1.042988699432748	SLC6A4
Antigen processing and presentation	1/78	0.4948445060126242	0.7497644030494306	0	0	1.4825463553787253	1.042988699432748	CIITA
Peroxisome	1/82	0.5122641310571929	0.7531961346007172	0	0	1.4090487404552916	0.9425337057603482	SOD2
Pathogenic Escherichia coli infection	2/197	0.5131041647969756	0.7531961346007172	0	0	1.170602265951103	0.7811152706982241	CASP8;WIPF1
Complement and coagulation cascades	1/85	0.5249357054640315	0.7531961346007172	0	0	1.3585191301954307	0.8755377157391645	TFPI
ErbB signaling pathway	1/85	0.5249357054640315	0.7531961346007172	0	0	1.3585191301954307	0.8755377157391645	CDKN1A
Colorectal cancer	1/86	0.529086394818438	0.7531961346007172	0	0	1.3424685481128869	0.8546202343921173	CDKN1A
Insulin secretion	1/86	0.529086394818438	0.7531961346007172	0	0	1.3424685481128869	0.8546202343921173	KCNN2
Proteoglycans in cancer	2/205	0.534462907466046	0.7531961346007172	0	0	1.1240119143086265	0.7041855373563239	CDKN1A;FGFR1
Gap junction	1/88	0.5372799093485117	0.7531961346007172	0	0	1.3114743206431467	0.8147351578668095	GJA1
Rap1 signaling pathway	2/210	0.5474851608273558	0.7536863288631251	0	0	1.0967128801431127	0.6606816868024498	SIPA1L1;FGFR1
Lipid and atherosclerosis	2/215	0.5602524059188213	0.7536863288631251	0	0	1.070695490774102	0.6203265679896567	CASP8;SOD2
Phosphatidylinositol signaling system	1/97	0.5724313282017013	0.7536863288631251	0	0	1.1879816955684008	0.6627304404114991	PIK3C3
Aldosterone synthesis and secretion	1/98	0.5761692938908964	0.7536863288631251	0	0	1.1756748703891307	0.6482127467653656	NPPA
Hematopoietic cell lineage	1/99	0.5798747669908522	0.7536863288631251	0	0	1.1636192049073966	0.634106277380677	CD34
AGE-RAGE signaling pathway in diabetic complications	1/100	0.58354802824362	0.7536863288631251	0	0	1.1518070882232732	0.6203961472877585	EDN1
Progesterone-mediated oocyte maturation	1/100	0.58354802824362	0.7536863288631251	0	0	1.1518070882232732	0.6203961472877585	CPEB4
Chagas disease	1/102	0.5907990265731289	0.7536863288631251	0	0	1.1288845647570538	0.594108664280511	CASP8
Pancreatic secretion	1/102	0.5907990265731289	0.7536863288631251	0	0	1.1288845647570538	0.594108664280511	SLC4A4
Protein digestion and absorption	1/103	0.594377313347594	0.7536863288631251	0	0	1.1177603989572709	0.5815047358751091	SLC8A1
Toll-like receptor signaling pathway	1/104	0.5979244875647459	0.7536863288631251	0	0	1.106852236376901	0.5692439309609706	CASP8
C-type lectin receptor signaling pathway	1/104	0.5979244875647459	0.7536863288631251	0	0	1.106852236376901	0.5692439309609706	CASP8
Calcium signaling pathway	2/240	0.6202111313962009	0.7752639142452511	0	0	0.9570060582372484	0.45715731944404875	SLC8A1;FGFR1
Alzheimer disease	3/369	0.6256761186612213	0.7756315520593653	0	0	0.932796472054453	0.4374091828684266	CASP8;PIK3C3;MAPT
Salmonella infection	2/249	0.6402099637565081	0.7871433980612804	0	0	0.9217117032294511	0.41104571062785134	CASP8;PIK3C3
Osteoclast differentiation	1/127	0.671512859221495	0.8126879995539044	0	0	0.9037526378566841	0.35989428526407197	MITF
Oocyte meiosis	1/129	0.6772399996282537	0.8126879995539044	0	0	0.8895411849710982	0.34668049841991266	CPEB4
Relaxin signaling pathway	1/129	0.6772399996282537	0.8126879995539044	0	0	0.8895411849710982	0.34668049841991266	EDN1
Autophagy	1/137	0.6991726429357337	0.8182943332353988	0	0	0.8368752125127508	0.29948213968623344	PIK3C3
Yersinia infection	1/137	0.6991726429357337	0.8182943332353988	0	0	0.8368752125127508	0.29948213968623344	WIPF1
Estrogen signaling pathway	1/137	0.6991726429357337	0.8182943332353988	0	0	0.8368752125127508	0.29948213968623344	NCOA2
Measles	1/139	0.7044201640031796	0.8182943332353988	0	0	0.8246628131021194	0.28894558487351746	CASP8
Apoptosis	1/142	0.7121212759335521	0.8182943332353988	0	0	0.806993809699504	0.27398008827033093	CASP8
Spinocerebellar ataxia	1/143	0.7146437176922483	0.8182943332353988	0	0	0.8012700480338679	0.2692036254384872	PIK3C3
Phagosome	1/152	0.7363792647376993	0.836794619020113	0	0	0.7531677066186885	0.23047684058369247	PIK3C3
Necroptosis	1/159	0.752139644984171	0.8482777950949297	0	0	0.7195434257701032	0.20494990985866682	CASP8
Hippo signaling pathway	1/163	0.7607211888443749	0.8515535696019121	0	0	0.7016341968172412	0.19188878788696193	ID2
Pathways of neurodegeneration	3/475	0.7854426836658039	0.8727140929620044	0	0	0.7193725840023788	0.17373408432358806	CASP8;PIK3C3;MAPT
NOD-like receptor signaling pathway	1/181	0.7958246957887586	0.8733035360740048	0	0	0.6308927424534361	0.14408098101439612	CASP8
Axon guidance	1/182	0.7976172296142577	0.8733035360740048	0	0	0.6273752115734679	0.14186613489721012	SLIT2
PI3K-Akt signaling pathway	2/354	0.8163533758577014	0.8873406259322841	0	0	0.6433007399577167	0.13053084023987951	CDKN1A;FGFR1
Human immunodeficiency virus 1 infection	1/212	0.8446922498634462	0.9115383991332152	0	0	0.5373530942662247	0.0906960239491257	CASP8
Regulation of actin cytoskeleton	1/218	0.8527090429140258	0.9136168316935991	0	0	0.5223355797661223	0.08322732590457917	FGFR1
Ras signaling pathway	1/232	0.8698505193832657	0.9216754584895541	0	0	0.49032855391236896	0.06836842201230839	FGFR1
Chemical carcinogenesis	1/239	0.8776620150002892	0.9216754584895541	0	0	0.47573711565551074	0.062080700352939513	E2F1
Shigellosis	1/246	0.8850071940510019	0.9216754584895541	0	0	0.46197947387047306	0.05643518391103343	PIK3C3
Parkinson disease	1/249	0.8880192979059618	0.9216754584895541	0	0	0.4563210889427559	0.0541935158858066	MAPT
Endocytosis	1/252	0.8909529432065689	0.9216754584895541	0	0	0.4507979642125141	0.05205078573859812	WIPF1
Cytokine-cytokine receptor interaction	1/295	0.9254978589383261	0.9508539646626639	0	0	0.38401950375525934	0.029732118834925027	ACVR2A
Herpes simplex virus 1 infection	2/498	0.9331363745307508	0.9521799740109702	0	0	0.45316016504126033	0.03136046028217478	CASP8;ZNF184
Neuroactive ligand-receptor interaction	1/341	0.950479932910486	0.9633242563281954	0	0	0.33128187691261474	0.016825219966327146	EDN1
Amyotrophic lateral sclerosis	1/364	0.9596417488000474	0.9660822974497122	0	0	0.3099253172821223	0.012767448602915753	PIK3C3
Olfactory transduction	1/440	0.979506816354821	0.979506816354821	0	0	0.25527012258548726	0.005285644245388517	SLC8A1
